Combination strategy enables brain-specific kinase inhibition

Sep. 15, 2022

Using a two-drug combination, researchers at the University of California at San Francisco (UCSF) have been able to achieve brain-specific inhibition of several kinases.

BioWorld BioWorld Science Science Drug design, drug delivery and technologies Cancer Neurology/psychiatric

Today's news in brief

BioWorld

BioWorld briefs for Aug. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Aug. 21, 2025.

FDA approved icons and medical professional

Ionis gets approval for preventing attacks in rare and genetic HAE

BioWorld

In Ionis Pharmaceuticals Inc.’s second U.S. FDA approval in under a year, the agency approved Dawnzera (donidalorsen) as a prophylactic therapy in the rare and...

Elderly woman holding illustration of brain with missing puzzle piece

Marvel Biotechnology’s MB-204 as therapeutic agent for Alzheimer’s disease

BioWorld Science

Phosphorylation of the protein Tau is a key post-translational feature in tauopathies like Alzheimer’s disease (AD), which leads to microtubule dysfunction and...

Wooden blocks spelling TARIFFS with a U.S. flag on top, placed on a map of Europe

EU, US lock in 15% max Rx tariff, no relief for medtech

BioWorld

No matter what level of tariff the Trump administration ends up imposing on biopharmaceuticals across the world, drugs and their precursors originating in the EU...